Sponsorship and Support: This webinar is sponsored by Primary Care Education Consortium, in collaboration with the Primary Care Metabolic Group. It is supported by an educational grant from Novo Nordisk.
Accreditation: The Southern Medical Association (SMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: The Southern Medical Association designates this enduring activity for a maximum of 5.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Certificates of participation are provided to attendees not eligible for AMA PRA Category 1 CreditsTM. The term of approval is from October 19, 2025, to April 25, 2026.
Faculty Disclosure Information: SMA adheres to the conflict-of-interest policy of the ACCME and the AMA. It is the policy of SMA to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. All individuals in a position to control the content in our programs are expected to disclose any relationships they may have with commercial companies whose products or services may be mentioned so that participants may evaluate the objectivity of the presentations. In addition, any discussion of off-label, experimental, or investigational use of drugs or devices will be disclosed by the faculty. Only those participants who have no conflict of interest or who agree to an identified mitigation process prior to their participation were involved in the CME activity.
Stephen Brunton, MD, discloses that he serves as a speaker for Lilly and AstraZeneca, and as an advisory board member for Abbott, Insulet, Biolinq, Novo Nordisk, and Phathom. He holds stock options for Paracrine.
James Gavin, MD, discloses that he serves as an advisor for Abbott Diabetes Care, and has served in the recent past as a speaker for Boehringer Ingelheim.
Jennifer Goldman, PharmD, discloses that she serves as a speaker for Lilly, Novo Nordisk, Amgen, Abbott Diabetes Care, Xeris and Cequr.
Louis Kuritzky, MD, discloses that he serves as a consultant to Roche Diagnostics.
Eden Miller, DO, discloses that she serves as a speaker for Bayer, Boehringer Ingelheim, Lilly, Novo Nordisk, Abbott, Insulet, Embecta, and Corcept; as a researcher for Abbott; and as an advisory board member for Boehringer Ingelheim, Lilly, Abbott, Embecta, Insulet and Novo Nordisk.
Lenard Salzberg, MD, faculty, Austin Ulrich, PharmD, medical writer, Desma Rozovics, Project Manager, and Nora Williams, PCEC COO, have no relevant financial disclosures to report.
All relevant financial relationships have been mitigated.
Learning Objectives: After viewing this webinar, participants should be able to
- Develop strategies for improving patient adherence to diabetes regimens, including effective self-management.
- Analyze and apply methods for overcoming therapeutic inertia in diabetes management, such as motivational interviewing and shared decision-making.
- Describe effective dietary, exercise, and psychosocial interventions for patients with diabetes.
- Review evidence-based recommendations from the most recent clinical society guidelines across the spectrum of diabetes management.
- Design individualized treatment regimens that include appropriate dosing strategies for antihyperglycemic drugs based on patient characteristics and treatment response.
- Compare and contrast the various types of insulin as well as the risks and benefits of insulin therapy for a given patient.
- Prescribe therapeutic regimens for patients with type 2 diabetes (T2D) that incorporate drugs with benefits for comorbid conditions, including GLP-1 receptor agonists, and SGLT-2 inhibitors.
Note that, while you may complete the webinars at your convenience, you will need to complete all five chapters to receive credit.
Chapter One: Lifestyle Interventions (40 minutes)
Chapter Two: Pharmacology I (44 minutes)
Chapter Three: Pharmacology II (89 minutes)
Chapter Four: Initiating Insulin (62 minutes)
Chapter Five: Intensifying Insulin (69 minutes)
To receive your certificate after watching all five chapters of the webinar, click HERE to complete the evaluation survey.
Thanks for watching our webinar!
In addition, as a special bonus, visit https://www.pcmg-us.org/webinar/h2c for a bonus 1.0 CME/CE webinar on hard-to-control diabetes!
